Hey 3rd door.. I think Lopez meant the adverse effects of...

First 9 Last

Share
Profile

Follow
Whatsamadoovie

3,656 Posts.

699

17/01/18

11:59

Post #: 30369647
Share

Originally posted by 3rddoor ↑

Hi Lopez,

I am happy for criticism, but I would like the assertions backed up. This can be a discussion.

I cannot see how going to phase 3 has any major adverse affects other than money. The problem I see is lots of small players have a carrot dangled in front of them by major players. The major players are not always charitable and are in the game for different reasons to us. I see our best efforts are to get to it and make sure we have a product that works and is approved by FDA. The danger is that we may find out that it isnt as good as other drugs, this is the risk I am willing to take, I have confidence in the product.

Expand

Hey 3rd door..

I think Lopez meant the adverse effects of keytruda and chemo.. not for phase 3 trials..

I don’t think you will get any argument from anyone on HC about going to phase 3, especially if we have the cash..

Thanks for everyone else’s input about keynote 200.. I should have known that..

VLA Price at posting: 72.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Clarity confidence – and share price – up on bumper $203M institutional placement

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

BOE

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Hey 3rd door.. I think Lopez meant the adverse effects of...

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Clarity confidence – and share price – up on bumper $203M institutional placement

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

Featured News